Abstract
The 'gold standard' for the treatment of polycythemia vera (PV) is to date undefined. We performed a retrospective analysis to evaluate the outcome of a cohort of PV patients treated with pipobroman (PB) at a single institution during a period of 20 years (November 1971-October 1991). During this period, a total of 366 adult PV patients were diagnosed according to Polycythemia Vera Study Group (PVSG) criteria. Of these, only 199 (54%) were treated with PB: 92 were males and 107 females, median age was 63.0 years (range 25.2-87.3 years). Major clinical characteristics at onset were as follows: 34 (17%) patients had splenomegaly >3 cm below costal margin, 70 (35%) had platelets >600,000/mm3, 79 (40%) had white blood cells >12,000 mm3; 97 (49%) had hypertension, 83 (42%) had minor neurological symptoms (as vertigo, headache, paresthesias), 33 (17%) had pruritus and 27 (13%) had thrombotic features. All patients received PB at the dosage of 1 mg/kg/day until response was achieved (hematocrit value <50% in males and <45% in females). Thereafter treatment was given according to toxicity and maintenance of response. All patients were phlebotomized before starting treatment (mean number of phlebotomies performed: three, range 2-4) and ...Continue Reading
Citations
May 5, 1999·Critical Reviews in Oncology/hematology·T Barbui, G Finazzi
Jan 1, 2011·Blood Cancer Journal·A TefferiT Mughal
Feb 14, 2002·British Journal of Haematology·Jerry L Spivak
Dec 1, 2009·Journal of Medical Case Reports·Ming-Shyan LinPao-Hsien Chu
Sep 13, 2000·Drugs & Aging·P J van Genderen, M M Troost
Oct 21, 2003·Leukemia & Lymphoma·Francesco Passamonti, Mario Lazzarino
May 30, 2001·Leukemia & Lymphoma·G LeoneL Pagano
Jul 12, 2011·Blood Reviews·A Tefferi, A Pardanani
Feb 14, 2003·Mayo Clinic Proceedings·Ayalew Tefferi
Jan 23, 2015·American Journal of Hematology·Ayalew Tefferi, Tiziano Barbui
Jan 29, 2008·European Journal of Haematology·Ayalew TefferiCurtis A Hanson
Mar 14, 2007·Hematological Oncology·Mary Frances McMullin
Feb 26, 2011·American Journal of Hematology·Ayalew Tefferi
Feb 15, 2012·American Journal of Hematology·Ayalew Tefferi
Jul 6, 2010·European Journal of Clinical Investigation·Kamal S SainiAyalew Tefferi
May 23, 2013·American Journal of Hematology·Ayalew Tefferi
Feb 26, 2011·American Journal of Hematology·Ayalew Tefferi
Apr 24, 2016·Annals of Hematology·Brianna E VaaAlexandra P Wolanskyj
Sep 3, 2013·Leukemia Research·Mohamad CherrySrdan Verstovsek
Jul 13, 2016·Critical Reviews in Oncology/hematology·Aziz NazhaNaval Daver
Dec 20, 2016·American Journal of Hematology·Ayalew Tefferi, Tiziano Barbui
Nov 18, 2003·British Journal of Haematology·Vitaliana De SanctisFranco Mandelli
Oct 4, 2018·American Journal of Hematology·Ayalew Tefferi, Tiziano Barbui
Dec 1, 2007·The British Journal of Dermatology·J HafijiN P Burrows
Mar 16, 2016·The Oncologist·Aziz Nazha, Aaron T Gerds
Sep 26, 2020·American Journal of Hematology·Ayalew Tefferi, Tiziano Barbui